KOSPI, Foreign Buying Influx... Touches 2180 Level Intraday

[Asia Economy Reporter Oh Ju-yeon] Supported by expectations of China's economic stimulus policies, foreign buying continued for the second consecutive trading day, leading to a rise in the domestic stock market. This is interpreted as a result of improved risk asset preference sentiment, following the previous day's rise in the U.S. stock market and the Nasdaq index reaching an all-time high.

As of 9:30 a.m. on the 5th, the KOSPI recorded 2172.29, up 0.67% from the previous trading day. The KOSPI opened at 2177.26 (0.90%) and quickly rose to 2181.52 during the session, marking an increase of over 1%.

Seosangyoung, a researcher at Kiwoom Securities, predicted before the market opened, "The expectation for China's economic stimulus policy, which was a strong factor for the Korean stock market yesterday, is still ongoing and will have a positive effect on improving investor sentiment."

By supply and demand, individuals and foreigners net bought 149.3 billion KRW and 171.1 billion KRW respectively, while institutions sold 323.3 billion KRW.

Among the top market capitalization stocks, Samsung Electronics rose 2.21% during the session, recovering to the 60,000 KRW level (60,200 KRW). SK Hynix (1.03%), Samsung Biologics (0.71%), LG Chem (0.92%), and Samsung SDI (1.79%) also rose. NAVER (-0.28%), Hyundai Mobis (-0.65%), and Celltrion (-0.30%) declined.

The KOSDAQ index recorded 666.50, up 0.81% from the previous trading day. Individuals net bought 35.1 billion KRW, while foreigners and institutions net sold 19.6 billion KRW and 11.9 billion KRW respectively.

Among the top market capitalization stocks, Celltrion Healthcare (-0.90%) and Medytox (-1.01%) declined, while HL Biopharma (0.71%), CJ ENM (2.01%), Pearl Abyss (0.76%), Studio Dragon (0.47%), and KMW (0.38%) rose.

This content was produced with the assistance of AI translation services.